These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1660 related articles for article (PubMed ID: 26181352)

  • 21. Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer.
    Masugi Y; Nishihara R; Hamada T; Song M; da Silva A; Kosumi K; Gu M; Shi Y; Li W; Liu L; Nevo D; Inamura K; Cao Y; Liao X; Nosho K; Chan AT; Giannakis M; Bass AJ; Hodi FS; Freeman GJ; Rodig SJ; Fuchs CS; Qian ZR; Nowak JA; Ogino S
    Cancer Immunol Res; 2017 Nov; 5(11):1046-1055. PubMed ID: 29038297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor SQSTM1 (p62) expression and T cells in colorectal cancer.
    Kosumi K; Masugi Y; Yang J; Qian ZR; Kim SA; Li W; Shi Y; da Silva A; Hamada T; Liu L; Gu M; Twombly TS; Cao Y; Barbie DA; Nosho K; Baba H; Garrett WS; Meyerhardt JA; Giovannucci EL; Chan AT; Fuchs CS; Ogino S; Nishihara R
    Oncoimmunology; 2017; 6(3):e1284720. PubMed ID: 28405513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes.
    Rosenbaum MW; Bledsoe JR; Morales-Oyarvide V; Huynh TG; Mino-Kenudson M
    Mod Pathol; 2016 Sep; 29(9):1104-12. PubMed ID: 27198569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marine ω-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer Characterized by Tumor-Infiltrating T Cells.
    Song M; Nishihara R; Cao Y; Chun E; Qian ZR; Mima K; Inamura K; Masugi Y; Nowak JA; Nosho K; Wu K; Wang M; Giovannucci E; Garrett WS; Fuchs CS; Ogino S; Chan AT
    JAMA Oncol; 2016 Sep; 2(9):1197-206. PubMed ID: 27148825
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Hussan H; Clinton SK; Roberts K; Bailey MT
    World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
    Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
    Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
    Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inverse relationship between
    Ugai T; Shimizu T; Kawamura H; Ugai S; Takashima Y; Usui G; Väyrynen JP; Okadome K; Haruki K; Akimoto N; Masugi Y; da Silva A; Mima K; Zhang X; Chan AT; Wang M; Garrett WS; Freeman GJ; Meyerhardt JA; Nowak JA; Song M; Giannakis M; Ogino S
    Clin Transl Immunology; 2023; 12(8):e1453. PubMed ID: 37538192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium Intake and Risk of Colorectal Cancer According to Tumor-infiltrating T Cells.
    Yang W; Liu L; Keum N; Qian ZR; Nowak JA; Hamada T; Song M; Cao Y; Nosho K; Smith-Warner SA; Zhang S; Masugi Y; Ng K; Kosumi K; Ma Y; Garrett WS; Wang M; Nan H; Giannakis M; Meyerhardt JA; Chan AT; Fuchs CS; Nishihara R; Wu K; Giovannucci EL; Ogino S; Zhang X
    Cancer Prev Res (Phila); 2019 May; 12(5):283-294. PubMed ID: 30760501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location.
    Mima K; Cao Y; Chan AT; Qian ZR; Nowak JA; Masugi Y; Shi Y; Song M; da Silva A; Gu M; Li W; Hamada T; Kosumi K; Hanyuda A; Liu L; Kostic AD; Giannakis M; Bullman S; Brennan CA; Milner DA; Baba H; Garraway LA; Meyerhardt JA; Garrett WS; Huttenhower C; Meyerson M; Giovannucci EL; Fuchs CS; Nishihara R; Ogino S
    Clin Transl Gastroenterol; 2016 Nov; 7(11):e200. PubMed ID: 27811909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome.
    Kosumi K; Hamada T; Koh H; Borowsky J; Bullman S; Twombly TS; Nevo D; Masugi Y; Liu L; da Silva A; Chen Y; Du C; Gu M; Li C; Li W; Liu H; Shi Y; Mima K; Song M; Nosho K; Nowak JA; Nishihara R; Baba H; Zhang X; Wu K; Wang M; Huttenhower C; Garrett WS; Meyerson ML; Lennerz JK; Giannakis M; Chan AT; Meyerhardt JA; Fuchs CS; Ogino S
    Am J Pathol; 2018 Dec; 188(12):2839-2852. PubMed ID: 30243655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
    Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
    Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.
    Cao Y; Nishihara R; Qian ZR; Song M; Mima K; Inamura K; Nowak JA; Drew DA; Lochhead P; Nosho K; Morikawa T; Zhang X; Wu K; Wang M; Garrett WS; Giovannucci EL; Fuchs CS; Chan AT; Ogino S
    Gastroenterology; 2016 Nov; 151(5):879-892.e4. PubMed ID: 27475305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate.
    Hanyuda A; Ogino S; Qian ZR; Nishihara R; Song M; Mima K; Inamura K; Masugi Y; Wu K; Meyerhardt JA; Chan AT; Fuchs CS; Giovannucci EL; Cao Y
    Int J Cancer; 2016 Aug; 139(4):854-68. PubMed ID: 27037951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.
    Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
    Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut.
    Bashir A; Miskeen AY; Hazari YM; Asrafuzzaman S; Fazili KM
    Tumour Biol; 2016 Mar; 37(3):2805-10. PubMed ID: 26718210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intratumour Fusobacterium nucleatum and immune response to oesophageal cancer.
    Kosumi K; Baba Y; Yamamura K; Nomoto D; Okadome K; Yagi T; Toihata T; Kiyozumi Y; Harada K; Eto K; Sawayama H; Ishimoto T; Iwatsuki M; Iwagami S; Miyamoto Y; Yoshida N; Watanabe M; Baba H
    Br J Cancer; 2023 Apr; 128(6):1155-1165. PubMed ID: 36599917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.
    Kostic AD; Chun E; Robertson L; Glickman JN; Gallini CA; Michaud M; Clancy TE; Chung DC; Lochhead P; Hold GL; El-Omar EM; Brenner D; Fuchs CS; Meyerson M; Garrett WS
    Cell Host Microbe; 2013 Aug; 14(2):207-15. PubMed ID: 23954159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients.
    Kunzmann AT; Proença MA; Jordao HW; Jiraskova K; Schneiderova M; Levy M; Liska V; Buchler T; Vodickova L; Vymetalkova V; Silva AE; Vodicka P; Hughes DJ
    Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1891-1899. PubMed ID: 31367996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
    Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
    J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 83.